Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Department of Radiation Oncology Publications 2012–June 30, 2013 1. Abrams RA, Winter KA, Regine WF, Safran H, Hoffman JP, Lustig R, Konski AA, Benson AB, Macdonald JS, Rich TA, Willett CG. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):809–816. Epub 2011 Feb 1. PMID: 21277694; PMCID: PMC313385. 2. Alexander BM, Wang M, Yung WK, Fine HA, Donahue BA, Tremont IW, Richards RS, Kerlin KJ, Hartford AC, Curran WJ, Mehta MP. A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806). J Neurooncol. 2013 Jan;111(1):33–39. Epub 2012 Oct 20. PMID: 23086432 3. Authors on behalf of ICRP, Stewart FA, Akleyev AV, Hauer-Jensen M, Hendry JH, Kleiman NJ, Macvittie TJ, Aleman BM, Edgar AB, Mabuchi K, Muirhead CR, Shore RE, Wallace WH. ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context. Ann ICRP. 2012 Feb;41(1–2):1–322. PMID: 22925378 4. Awan M, Cohen R, Campassi C, Kesmodel S, Bellavance E, Tkaczuk K, Feigenberg S. Breast MRI and its impact in partial breast irradiation. Appl Radiat Oncol. 2013;[Oct]:6–10. 5. Balcer-Kubiczek EK. Apoptosis in radiation therapy: a double-edged sword. Exp Oncol. 2012 Oct;34(3):277–285. PMID: 23070013 6. Barnholtz-Sloan JS, Yu C, Sloan AE, Vengoechea J, Wang M, Dignam JJ, Vogelbaum MA, Sperduto PW, Mehta MP, Machtay M, Kattan MW. A nomogram for individualized estimation of survival among patients with brain metastasis. Neuro Oncol. 2012 Jul;14(7):910–918. Epub 2012 Apr 27. PMID: 22544733; PMCID: PMC3379797 7. Batinic-Haberle I, Spasojevic I, Tse HM, Tovmasyan A, Rajic Z, St Clair DK, Vujaskovic Z, Dewhirst MW, Piganelli JD. Design of Mnporphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities. Amino acids. 2012;42:95–113. Erratum in: Amino Acids. 2012 Jan;42(1):115-6. PubMed PMID: 20473774; PubMed Central PMCID: PMC3022969. 8. Beazley KE, Banyard D, Lima F, Deasey SC, Nurminsky DI, Konoplyannikov M, Nurminskaya MV. Transglutaminase inhibitors attenuate vascular calcification in a preclinical model. Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):43–51. Epub 2012 Nov 1. PubMed PMID: 23117658; PubMed Central PMCID: PMC3544469 9. Beazley KE, Zhang T, Lima F, Pozharskaya T, Niger C, Tzitzikov E, Azimzadeh AM, Nurminskaya M. Implication for transglutaminase 2-mediated activation of β-catenin signaling in neointimal vascular smooth muscle cells in chronic cardiac allograft rejection. J Heart Lung Transplant. 2012 Sep;31(9):1009–1017. Epub 2012 Jun 12. PubMed PMID: 22694852; PubMed Central PMCID: PMC3509739 10. Beazley KE, Deasey S, Lima F, Nurminskaya MV. Transglutaminase 2-mediated activation of βcatenin signaling has a critical role in warfarin-induced vascular calcification. Arterioscler Thromb Vasc Biol. 2012 Jan;32(1):123–130. PubMed PMID: 22034513; PubMed Central PMCID: PMC3374407 11. Betof AS, Rabbani ZN, Hardee ME, Kim SJ, Broadwater G, Bentley RC, Snyder SA, Vujaskovic Z, Oosterwijk E, Harris LN, Horton JK, Dewhirst MW, Blackwell KL. Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification. Br J Cancer. 2012 Feb 28;106(5):916–922. Epub 2012 Feb 14. PMID: 22333602; PMCID: PMC3305967 1 12. Betzel GT, Yi BY, Niu Y, Yu CX. Is RapidArc more susceptible to delivery uncertainties than dynamic IMRT? Med Phys. 2012 Oct;39(10):5882–5890. PMID: 23039627; PMCID: PMC3461049 13. Biermann JS, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Butrynski JE, Cheong D, Chow W, Curry WT, Frassica DA, Frassica FJ, Hande KR, Hornicek FJ, Jones RL, Mayerson J, McGarry SV, McGrath B, Morris CD, O'Donnell RJ, Randall RL, Santana VM, Satcher RL, Siegel HJ, von Mehren M, Bergman MA, Sundar H. Bone cancer. J Natl Compr Canc Netw. 2013 Jun 1;11(6):688–723. PMID: 23744868 14. Bissonnette J-P, Balter PA, Dong L, Langen KM, Lovelock DM, Miften M, Moseley DJ, Pouliot J, Sonke J-J, Yoo S. Quality assurance for image-guided radiation therapy utilizing CT-based technologies: A report of the AAPM TG-179. Med Phys. 2012;39(4):1946–1963. PubMed PMID: 22482616. 15. Booth C, MacVittie T; MCART Team. Christopher S. Potten, 1940–2012. Health Phys. 2012 Oct;103(4):339. PMID: 22929465 16. Booth C, Tudor G, Tonge N, Shea-Donohue T, MacVittie TJ. Evidence of delayed gastrointestinal syndrome in high-dose irradiated mice. Health Phys. 2012 Oct;103(4):400–410. PMID: 23091877; PMCID: PMC3551349 17. Booth C, Tudor G, Tudor J, Katz BP, MacVittie TJ. Acute gastrointestinal syndrome in high-dose irradiated mice. Health Phys. 2012 Oct;103(4):383–399. PMID: 23091876; PMCID: PMC3530834 18. Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner J, Fink K, Souhami L, Laperriere N, Curran W, Mehta M. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2013 Jan 20;31(3):337–343. Epub 2012 Oct 15. PMID: 23071247 19. Chakravarti A, Wang M, Robins HI, Lautenschlaeger T, Curran WJ, Brachman DG, Schultz CJ, Choucair A, Dolled-Filhart M, Christiansen J, Gustavson M, Molinaro A, Mischel P, Dicker AP, Bredel M, Mehta M. RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1206– 1211. Epub 2012 Nov 22. PMID: 23182702 20. Chinnaiyan P, Won M, Wen PY, Rojiani AM, Wendland M, Dipetrillo TA, Corn BW, Mehta MP. RTOG 0913: A phase 1 study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys. 2013 May 29. [Epub ahead of print] PMID: 23725999 21. Choi M, Hayes JP, Mehta MP, Swisher A, Small WJ, Mittal BB, Macvicar GR, Kalapurakal JA, Sejpal SV. Using intensity-modulated radiotherapy to spare the kidney in a patient with seminoma and a solitary kidney: a case report. Tumori. 2013 Mar-Apr;99(2):38e–42e. PMID: 23748827 22. Chua HL, Plett PA, Sampson CH, Joshi M, Tabbey R, Katz BP, MacVittie TJ, Orschell CM. Long-term hematopoietic stem cell damage in a murine model of the hematopoietic syndrome of the acute radiation syndrome. Health Phys. 2012 Oct;103(4):356–366. PMID: 22929468 23. Chung H, Lim S, Court L, Balter P. Evaluation of dose variation to normal/critical structures for lung hypofractionated stereotactic body radiation therapy. Practical Radiat Oncol. 2012;2(2): 24. DiCarlo AL, Jackson IL, Shah JR, Czarniecki CW, Maidment BW, Williams JP. Development and licensure of medical countermeasures to treat lung damage resulting from a radiological or nuclear incident. Radiat Res. 2012 May;177(5):717–721. Epub 2012 Apr 2. PMID: 22468704 25. Dipetrillo T, Suntharalingam M, Ng T, Fontaine J, Horiba N, Oldenburg N, Perez K, Birnbaum A, Battafarano R, Burrows W, Safran H. Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trial. Am J Clin Oncol. 2012 Feb;35(1):64–67. PMID: 21297434 26. Dragan AI, Albrecht MT, Pavlovic R, Keane-Myers AM, Geddes CD. Ultra-fast pg/ml anthrax toxin (protective antigen) detection assay based on microwave-accelerated metal-enhanced fluorescence. Anal Biochem. 2012 Jun 1;425(1):54–61. Epub 2012 Mar 6. PMID: 22406431 2 27. Dragan AI, Pavlovic R, McGivney JB, Casas-Finet JR, Bishop ES, Strouse RJ, Schenerman MA, Geddes CD. SYBR Green I: fluorescence properties and interaction with DNA. J Fluoresc. 2012 Jul;22(4):1189–1199. Epub 2012 Apr 26. PMID: 22534954 28. Farese AM, Cohen MV, Katz BP, Smith CP, Gibbs A, Cohen DM, MacVittie TJ. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat Res. 2013 Jan;179(1):89–100. Epub 2012 Dec 4. PMID: 23210705 29. Farese AM, Cohen MV, Katz BP, Smith CP, Jackson W 3rd, Cohen DM, MacVittie TJ. A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management. Health Phys. 2012 Oct;103(4):367–382. PMID: 22929469 30. Farese AM, Cohen MV, Stead RB, Jackson W 3rd, Macvittie TJ. Pegfilgrastim administered in an abbreviated schedule, significantly improved neutrophil recovery after high-dose radiation-induced myelosuppression in rhesus macaques. Radiat Res. 2012 Nov;178(5):403–413. Epub 2012 Sep 19. PMID: 22991919 31. Feigenberg SJ, Campassi C, Sharma N, Yu JQ, Kesmodel SB, Patel R, Tkaczuk K. Integration of modern imaging into the multidisciplinary setting: the radiation oncology perspective. Appl Radiol. 2013; available at: www.appliedradiology.com/Article.aspx?id=27246&terms=feigenberg. 32. Feliciano J, Feigenberg S, Mehta M. Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancer. Cancer J. 2013 May–Jun;19(3):222–230. PMID: 23708069 33. Gaugler JE, Eppinger A, King J, Sandberg T, Regine WF. Coping and its effects on cancer caregiving. Support Care Cancer. 2013 Feb;21(2):385–395. Epub 2012 Jun 21. PMID: 22717917 34. Ghobadi K, Ghaffari HR, Aleman DM, Jaffray DA, Ruschin M. Automated treatment planning for a dedicated multi-source intracranial radiosurgery treatment unit using projected gradient and grassfire algorithms. Med Phys. 2012 Jun;39(6):3134–141. PMID: 22755698 35. Gilbert MR, Kuhn J, Lamborn KR, Lieberman F, Wen PY, Mehta M, Cloughesy T, Lassman AB, Deangelis LM, Chang S, Prados M. Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery. J Neurooncol. 2012 Jan;106(1):147–153.. Epub 2011 Jul 8. PMID: 21739168 36. Gleason JF Jr, Kudrimoti M, Van Meter EM, Mohuiddin M, Regine WF, Valentino J, Kenady D, Arnold SM. Low-dose fractionated radiation with induction chemotherapy for locally advanced head and neck cancer: 5-year results of a prospective phase II trial. J Radiat Oncol. 2013;2(1):35–?. 37. Gojo I, Tan M, Fang HB, Sadowska M, Lapidus R, Baer MR, Carrier F, Beumer JH, Anyang BN, Srivastava RK, Espinoza-Delgado I, Ross DD. Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia. Clin Cancer Res. 2013 Apr 1;19(7):1838–1851. Epub 2013 Feb 12. PMID: 23403629 38. Gondi V, Hermann BP, Mehta MP, Tomé WA. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e487–e493. Epub 2011 Dec 29. PMID: 22209148; PMCID: PMC3462659 39. Goodman KA, Regine WF, Dawson LA, Ben-Josef E, Haustermans K, Bosch WR, Turian J, Abrams RA. Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):901–908. Epub 2012 Apr 5. PMID: 22483737 40. Grace MB, Singh VK, Rhee JG, Jackson WE 3rd, Kao TC, Whitnall MH. 5-AED enhances survival of irradiated mice in a G-CSF-dependent manner, stimulates innate immune cell function, reduces radiation-induced DNA damage and induces genes that modulate cell cycle progression and apoptosis. J Radiat Res. 2012 Nov 1;53(6):840-53. Epub 2012 Jul 22. PubMed PMID: 22843381; PubMed Central PMCID: PMC3483857. 3 41. Guzzetta AA, Montgomery EA, Lyu H, Hooker CM, Meyer CF, Loeb DM, Frassica D, Weber KL, Ahuja N. Epithelioid sarcoma: one institution's experience with a rare sarcoma. J Surg Res. 2012 Sep;177(1):116–122. Epub 2012 May 1. PMID: 22575361 42. Haisfield-Wolfe ME, McGuire DB, Soeken K, Geiger-Brown J, De Forge B, Suntharalingam M. Prevalence and correlates of symptoms and uncertainty in illness among head and neck cancer patients receiving definitive radiation with or without chemotherapy. Support Care Cancer. 2012 Aug;20(8):1885–1893. Epub 2011 Oct 4. PMID: 21964642 43. Harper J, Skerry C, Davis SL, Tasneen R, Weir M, Kramnik I, Bishai WR, Pomper MG, Nuermberger EL, Jain SK. Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions. J Infect Dis. 2012;4:595–602. PMID:22198962. Article in PMC, no ID. 44. Hendry J, MacVittie T. Professor Christopher S. Potten (1940–2012). Int J Radiat Biol. 2013 Jan;89(1):65–66. Epub 2012 Oct 23. PMID: 23088723 45. Hoang T, Dahlberg SE, Schiller JH, Mehta MP, Fitzgerald TJ, Belinsky SA, Johnson DH. Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer: the ECOG 3598 study. J Clin Oncol. 2012 Feb 20;30(6):616–622. Epub 2012 Jan 23. PMID: 22271472; PMCID: PMC3295560 46. Howell DD, James JL, Hartsell WF, Suntharalingam M, Machtay M, Suh JH, Demas WF, Sandler HM, Kachnic LA, Berk LB. Single-fraction radiotherapy versus multifraction radiotherapy for palliation of painful vertebral bone metastases-equivalent efficacy, less toxicity, more convenient: a subset analysis of Radiation Therapy Oncology Group trial 97-14. Cancer. 2013 Feb 15;119(4):888–896. Epub 2012 Nov 16. PMID: 23165743 47. Hu J, Sorensen E, Romar L, Hiivala NJ, Deers L, Gayden J, Watkins AC, Griffith BP, Wu ZJ. Platelet glycoprotein Ib shedding: a nov continuous-flow left ventricular assist device (CF-LVAD), J Heart Lung Transpl. 2012;31(4):S189–S190. 48. Hussain A, Wu Y, Mirmiran A, DiBiase S, Goloubeva O, Bridges B, Mannuel H, Engstrom C, Dawson N, Amin P, Kwok Y. Long-term follow-up of a prospective trial of trimodality therapy of weekly paclitaxel, radiation, and androgen deprivation in high-risk prostate cancer with or without prior prostatectomy. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):167–174. Epub 2010 Oct 30. PMID: 21036487 49. Indig FE, Rybanska I, Karmakar P, Devulapalli C, Fu H, Carrier F, Bohr VA. Nucleolin inhibits G4 oligonucleotide unwinding by Werner helicase. PLoS One. 2012;7(6):e35229. Epub 2012 Jun 4. PMID: 22675465; PMCID: PMC3366963 50. Jackson IL, Xu P, Hadley C, Katz BP, McGurk R, Down JD, Vujaskovic Z. A preclinical rodent model of radiation-induced lung injury for medical countermeasure screening in accordance with the FDA animal rule. Health Phys. 2012 Oct;103(4):463–473. PMID: 22929472; PMCID: PMC3604892 51. Jackson IL, Zhang X, Hadley C, Rabbani Z, Zhang Y, Marks S, Vujaskovic Z. Temporal expression of hypoxia associated genes in lungs following thoracic irradiation. Free Radic Biol Med. 53(2):337–346. PMID: 22588005. 52. Jakacki RI, Burger PC, Zhou T, Holmes EJ, Kocak M, Onar A, Goldwein J, Mehta M, Packer RJ, Tarbell N, Fitz C, Vezina G, Hilden J, Pollack IF. Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study. J Clin Oncol. 2012 Jul 20;30(21):2648–2653. Epub 2012 Jun 4. PMID: 22665539 53. Keller LMM, Cohen R, Sopka DM, Li T, Li L, Anderson PA, Fowble BL, Freedman GM. Effect of bra use during radiation therapy for large-breasted women: acute toxicity and treated heart and lung volumes. Practical Radiat Oncol. 2013;3(1):9–15. PubMed PMID: 23459714; PubMed Central PMCID: PMC3580873. 4 54. Kelsey CR, Jackson IL, Langdon S, Owzar K, Hubbs J, Vujaskovic Z, Das S, Marks LB. Analysis of single nucleotide polymorphisms and radiation sensitivity of the lung assessed with an objective radiologic endpoint. Clin Lung Cancer. 2013 May;14(3):267–274. Epub 2013 Jan 10. PMID: 23313170; PMCID: PMC3643296 55. Kelsey CR, Jackson L, Langdon S, Owzar K, Hubbs J, Vujaskovic Z, Das S, Marks LB. A polymorphism within the promoter of the TGFβ1 gene is associated with radiation sensitivity using an objective radiologic endpoint. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e247–e255. Epub 2011 May 24. PMID: 21605940 56. Kim SY, Rhee JG, Song X, Prochownik EV, Spitz DR, Lee YJ. Breast cancer stem cell-like cells are more sensitive to ionizing radiation than non-stem cells: role of ATM. PLoS One. 2012;7(11):e50423. Epub 2012 Nov 21. PubMed PMID: 23185620; PubMed Central PMCID: PMC3503893. 57. Kimura M, Caso JR, Bañez LL, Koontz BF, Gerber L, Senocak C, Donatucci CF, Vujaskovic Z, Moul JW, Polascik TJ. Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy. BJU Int. 2012 Dec;110(11 Pt C):E931–E938. Epub 2012 Apr 23. PubMed PMID: 22520165. 58. Kimura M, Rabbani ZN, Zodda AR, Yan H, Jackson IL, Polascik TJ, Donatucci CF, Moul JW, Vujaskovic Z, Koontz BF. Role of oxidative stress in a rat model of radiation-induced erectile dysfunction. J Sex Med. 2012 Jun;9(6):1535–1549. Epub 2012 Apr 10. PMID: 22489731 59. Koltz MT, Polifka AJ, Saltos A, Slawson RG, Kwok Y, Aldrich EF, Simard JM. Long-term outcome of Gamma Knife stereotactic radiosurgery for arteriovenous malformations graded by the Spetzler-Martin classification. J Neurosurg. 2013 Jan;118(1):74–83. Epub 2012 Oct 19. PMID: 23082882 60. Koontz BF, Quaranta BP, Pura JA, Lee WR, Vujaskovic Z, Gerber L, Haake M, Anscher MS, Robertson CN, Polascik TJ, Moul JW. Phase 1 Trial of neoadjuvant radiation therapy before prostatectomy for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Jun 19. [Epub ahead of print] PMID: 23790772 61. Krupp DR, Xu PT, Thomas S, Dellinger A, Etchevers HC, Vekemans M, Gilbert JR, Ashley-Koch AE, Gregory SG. Transcriptome profiling of genes involved in neural tube closure during human embryonic development using long serial analysis of gene expression (Long-SAGE). Birth Defects Res A Clin Mol Teratol. 2012;94(9):683–692. PubMed PMID: 22806986; PubMed Central PMCID: PMC3438356. 62. Kruser TJ, McCabe BP, Mehta MP, Khuntia D, Campbell TC, Geye HM, Cannon GM. Reirradiation for locoregionally recurrent lung cancer: outcomes in small cell and non-small cell lung carcinoma. Am J Clin Oncol. 2013 Jan 24. [Epub ahead of print] PubMed PMID: 23357968. 63. Kruser TJ, Mehta MP, Robins HI. Pseudoprogression after glioma therapy: a comprehensive review. Expert Rev Neurother. 2013 Apr;13(4):389-403. PubMed PMID: 23545054. 64. Kwok YM, Irani FG, Tay KH, Yang CC, Padre CG, Tan BS. Effective dose estimates for cone beam computed tomography in interventional radiology. Eur Radiol. 2013 Jun 21. [Epub ahead of print] PMID: 23793520 65. Lall RR, Shafizadeh SF, Lee KH, Mao Q, Mehta M, Raizer J, Bendok BR, Chandler JP. Orbital metastasis of pituitary growth hormone secreting carcinoma causing lateral gaze palsy. Surg Neurol Int. 2013 Apr 18;4:59. PubMed PMID: 23646269; PubMed Central PMCID: PMC3640222 66. Langen KM, Chauhan B, Siebers JV, Moore JA, Kupelian P. The dosimetric effect of intrafraction prostate motion on step-and-shoot IMRT plans––magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans. Int J Radiat Oncol Biol Phys. 2012;84(5):1220– 1225. PubMed PMID: 22483699; PubMed Central PMCID: PMC3393775 67. Lee EQ, Kuhn J, Lamborn KR, Abrey L, DeAngelis LM, Lieberman F, Robins HI, Chang SM, Yung WK, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados MD, Cloughesy TF, Gilbert MR, Wen PY. Phase I/II study of sorafenib in combination with 5 68. 69. 70. 71. 72. 73. 74. 75. 76. 77. 78. 79. 80. temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02. Neuro Oncol. 2012 Dec;14(12):1511–1518. Epub 2012 Oct 24. PMID: 23099651; PMCID: PMC3499017 Li S, DeWeese T, Movsas B, Liu D, Frassica D, Kim J, Chen Q, Walker E. Initial validation and clinical experience with 3D optical-surface-guided whole breast irradiation of breast cancer. Technol Cancer Res Treat. 2012 Feb;11(1):57–68. PMID: 22181332 Li L, Li T, Cohen R, Anderson P, Goldstein L, Bleicher R, Freedman G. (2012) Identifying patients who may be candidates for a clinical trial of salvage accelerated partial breast irradiation after previous whole breast irradiation. Int J Breast Cancer. Article ID: 937658. Available at: www.hindawi.com/journals/ijbc/2012/937658/ Lim S, Ma SY, Jeung TS, Yi BY, Lee SH, Lee S, Cho SJ, Choi J. Development of a one-stop beam verification system using electronic portal imaging devices for routine quality assurance. Med Dosim. 2012 Autumn;37(3):296-304. Epub 2012 Jan 25. PubMed PMID: 22277157. Lin SH, George TJ, Ben-Josef E, Bradley J, Choe KS, Edelman MJ, Guha C, Krishnan S, Lawrence TS, Le QT, Lu B, Mehta M, Peereboom D, Sarkaria J, Seong J, Wang D, Welliver MX, Coleman CN, Vikram B, Yoo S, Chung CH; Participants on Workshop for Preclinical and Clinical Development of Radiosensitizers; National Cancer Institute. Opportunities and challenges in the era of molecularly targeted agents and radiation therapy. J Natl Cancer Inst. 2013 May 15;105(10):686-93. Epub 2013 Mar 15. PMID: 23503600 Lu W, Tan S, Kim G, Feigenberg S, Zhang H, Kligerman S, Chen W, D’Souza WD, Suntharalingam. M. Pre-chemoradiation therapy FDG PET/CT cannot identify residual metabolically active areas in patients with locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;84(3 suppl):S312. Lubbe W, Cohen R, Sharma N, Ruth K, Peters R, Li J, Buyyounouski M, Kutikov A, Chen D, Uzzo R, Horwitz E. Biochemical and clinical experience with real-time intraoperatively planned permanent prostate brachytherapy. Brachytherapy. 2012;11(3):209–213. PubMed PMID: 21727033. MacVittie TJ, Bennett A, Booth C, Garofalo M, Tudor G, Ward A, Shea-Donohue T, Gelfond D, McFarland E, Jackson W 3rd, Lu W, Farese AM. The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation. Health Phys. 2012 Oct;103(4):427–453. PMID: 22929471 MacVittie TJ, Farese AM, Bennett A, Gelfond D, Shea-Donohue T, Tudor G, Booth C, McFarland E, Jackson W 3rd. The acute gastrointestinal subsyndrome of the acute radiation syndrome: a rhesus macaque model. Health Phys. 2012 Oct;103(4):411–426. PMID: 22929470 MacVittie TJ. The MCART Consortium animal models series. Health Phys. 2012 Oct;103(4):340– 342. PMID: 22929466 Mahmood U, Errens M, Zimrin A, Hanna N, Amin P, Sharma N. The remarkably distensible stomach: case report highlighting the implications of gastric filling on radiation treatment planning for gastric lymphoma. Practical Radat Oncol. 2012;2(4):265–269. Mahmood U, Hanlon AL, Koshy M, Buras R, Chumsri S, Tkaczuk KH, Cheston SB, Regine WF, Feigenberg SJ. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol. 2013 May;20(5):1436–1443. Epub 2012 Nov 8. PMID: 23135312 Mahmood U, Morris C, Neuner G, Koshy M, Kesmodel S, Buras R, Chumsri S, Bao T, Tkaczuk K, Feigenberg S. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1387–1393. Epub 2012 Jan 31. PMID: 22300561 Malinowski KT, McAvoy TJ, George R, Dieterich S, D’Souza WD. Incidence of changes in respiration-induced tumor motion and its relationship with respiratory surrogates during individual treatment fractions. Int J Radiat Oncol Biol Phys. 2012;82:1665–1773. PubMed PMID: 22429333; PubMed Central PMCID: PMC3346954. 6 81. Malinowski K, McAvoy TJ, George R, Dieterich S, D'Souza WD. Online monitoring and error detection of real-time tumor displacement prediction accuracy using control limits on respiratory surrogate statistics. Med Phys. 2012 Apr;39(4):2042–2048. PMID: 22482625; PubMed Central PMCID: PMC3321053 82. Malinowski KT, McAvoy TJ, George R, Dieterich S, D'Souza WD. Mitigating errors in external respiratory surrogate-based models of tumor position. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e709–e716. PMID: 22429333; PMCID: PMC3346954 83. McGurk R, Hadley C, Jackson IL, Vujaskovic Z. Development and dosimetry of a small animal lung irradiation platform. Health Phys. 2012 Oct;103(4):454–462. PMID: 23091878 84. Miriyala S, Spasojevic I, Tovmasyan A, Salvemini D, Vujaskovic Z, St Clair D, Batinic-Haberle I. Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta. 2012 May;1822(5):794–814. Epub 2011 Dec 9. Review. PMID: 22198225; PMCID: PMC3304004 85. Mistry N, Pokharel S, Diwanji T, Feigenberg S, D’Souza WD. SU-C-217BCD-01: Breathing maneuvers result in regional changes in ventilation as assessed by 4D-CT. Med Phys. 2012;39(6):3605. 86. Mutaf YD, Zhang J, Yu CX, Yi BY, Prado K, D'Souza WD, Regine WF, Feigenberg SJ. Dosimetric and geometric evaluation of a novel stereotactic radiotherapy device for breast cancer: the GammaPod™. Med Phys. 2013 Apr;40(4):041722. PMID: 23556892 87. Muvarak N, Nagaria P, Rassool FV. Genomic instability in chronic myeloid leukemia: targets for therapy? Curr Hematol Malig Rep. 2012 Jun;7(2):94–102. PMID: 22427031 88. Nagaria P, Robert C, Rassool FV. DNA double-strand break response in stem cells: mechanisms to maintain genomic integrity. Biochim Biophys Acta. 2013 Feb;1830(2):2345–2353. Epub 2012 Sep 17. PMID: 22995214 89. Nagaria P, Svilar D, Brown AR, Wang XH, Sobol RW, Wyatt MD. SMUG1 but not UNG DNA glycosylase contributes to the cellular response to recovery from 5-fluorouracil induced replication stress. Mutat Res. 2013 Mar-Apr;743-744:26–32. Epub 2012 Dec 17. PMID: 23253900; PMCID: PMC3616158 90. Neuner G, Mohiuddin MM, Vander Walde N, Goloubeva O, Ha J, Yu CX, Regine WF. High-dose spatially fractionated GRID radiation therapy (SFGRT): a comparison of treatment outcomes with Cerrobend vs. MLC SFGRT. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1642–1649. Epub 2011 Apr 29. PMID: 21531514 91. Neuner GA, Badros AA, Meyer TK, Nanaji NM, Regine WF. Complete resolution of laryngeal amyloidosis with radiation treatment. Head Neck. 2012 May;34(5):748–752. Epub 2010 Nov 10. PMID: 22488785 92. Nichols EM, Feigenberg SJ, Marter K, Cheston SB, Lasio G, Tkaczuk K, Kesmodel S, Buras R, Regine WF. Preoperative radiation therapy significantly increases patient eligibility for accelerated partial breast irradiation using 3D-conformal radiotherapy. Am J Clin Oncol. 2013 Jun;36(3):232– 238. PMID: 22549267 93. Nichols RC Jr, Huh SN, Prado KL, Yi BY, Sharma NK, Ho MW, Hoppe BS, Mendenhall NP, Li Z, Regine WF. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):158–163. Epub 2012 Jan 13. PMID: 22245197 94. Nieder C, Grosu AL, Mehta MP. Brain metastases research 1990-2010: pattern of citation and systematic review of highly cited articles. Sci World J. 2012;2012:721598. Epub 2012 Sep 17. Review. PMID: 23028253; PMCID: PMC3458272 95. Niu Y, Zhang G, Berman BL, Parke WC, Yi B, Yu CX. Improving IMRT-plan quality with MLC leaf position refinement post plan optimization. Med Phys. 2012 Aug;39(8):5118-26. PubMed PMID: 22894437; PubMed Central PMCID: PMC3416882. 96. Odén J, Toma-Dasu I, Yu CX, Feigenberg SJ, Regine WF, Mutaf YD. Dosimetric comparison between intra-cavitary breast brachytherapy techniques for accelerated partial breast irradiation and 7 a novel stereotactic radiotherapy device for breast cancer: GammaPod™. Phys Med Biol. 2013 Jul 7;58(13):4409–4421. Epub 2013 Jun 6. PMID: 23743718 97. Ogiwara H, Kalakota K, Rakhra SS, Helenowski IB, Marymont MH, Kalapurakal JA, Mehta MP, Levy RB, Chandler JP. Intracranial relapse rates and patterns, and survival trends following postresection cavity radiosurgery for patients with single intracranial metastases. J Neurooncol. 2012 May;108(1):141–146. Epub 2012 Mar 18. PMID: 22426925 98. Pamboukian R, Carrier F. hnRNP A18: A new pathway to regulate protein translation in cancer cells. Mol Cell Pharmacol. 2012;4(1):41–48. 99. Patel S, DiBiase S, Meisenberg B, Flannery T, Patel A, Dhople A, Cheston S, Amin P. Phase I clinical trial assessing temozolomide and tamoxifen with concomitant radiotherapy for treatment of high-grade glioma. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):739–742. Epub 2011 Feb 25. PMID: 21353747 100. Patel S, Macdonald OK, Nagda S, Bittner N, Suntharalingam M. Evaluation of the role of radiation therapy in the management of malignant thymoma. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1797–1801. Epub 2011 May 17. PMID: 21596484 101. Plett PA, Sampson CH, Chua HL, Joshi M, Booth C, Gough A, Johnson CS, Katz BP, Farese AM, Parker J, MacVittie TJ, Orschell CM. Establishing a murine model of the hematopoietic syndrome of the acute radiation syndrome. Health Phys. 2012 Oct;103(4):343–355. PMID: 22929467 102. Preusser M, Capper D, Ilhan-Mutlu A, Berghoff AS, Birner P, Bartsch R, Marosi C, Zielinski C, Mehta MP, Winkler F, Wick W, von Deimling A. Brain metastases: pathobiology and emerging targeted therapies. Acta Neuropathol. 2012 Feb;123(2):205–222. Epub 2012 Jan 3. PMID: 22212630 103. Raparia K, Villa C, DeCamp MM, Patel JD, Mehta MP. Molecular profiling in non-small cell lung cancer: a step toward personalized medicine. Arch Pathol Lab Med. 2013 Apr;137(4):481–491. PMID: 23544937 104. Richardson S, Garcia-Ramirez J, Lu W, Myerson RJ, Parikh P. Design and dosimetric characteristics of a new endocavitary contact radiotherapy system using an electronic brachytherapy source. Med Phys. 2012;39:6838–6846. PubMed PMID: 23127076. 105. Robert C, Rassool FV. HDAC inhibitors: roles of DNA damage and repair. Adv Cancer Res. 2012;116:87–129. PMID: 23088869. 106. Royak-Schaler R, Pelser C, Langenberg P, Hayes J, Gardner L, Nesbitt K, Citron W, Drogula CL, Dwyer D. Characteristics associated with the initiation of radiation therapy after breast-conserving surgery among African American and white women diagnosed with early-stage breast cancer in Maryland, 2000-2006. Ann Epidemiol. 2012 Jan;22(1):28–36. Epub 2011 Oct 28. PMID: 22037379 107. Rubinstein TJ, Mehta MP, Schoenfield L, Perry JD. Orbital xanthogranuloma in an adult patient with xanthelasma palpebrarum and hypercholesterolemia. Ophthal Plast Reconstr Surg. 2013 Mar 14. [Epub ahead of print] PMID: 23503059 108. Seung SK, Larson DA, Galvin JM, Mehta MP, Potters L, Schultz CJ, Yajnik SV, Hartford AC, Rosenthal SA. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS). Am J Clin Oncol. 2013 Jun;36(3):310–315. PMID: 23681017 109. Shaw EG, Wang M, Coons SW, Brachman DG, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta MP. Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. J Clin Oncol. 2012 Sep 1;30(25):3065–3070. Epub 2012 Jul 30. PMID: 22851558 110. Skerry CM, Harper J, Weir M, Bishai WR, Jain SK. Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas. PloS One. 2012;7(6):e39680. PubMed PMID: 22198962; PubMed Central PMCID: PMC3266133. 111. Smeenk RJ, Louwe RJW, Langen KM, Shah AP, Kupelian PA, van Lin ENJTh, Kaanders JHAM. An endorectal balloon reduces intrafraction prostate motion during radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(2):661–669. PubMed PMID: 22099035 8 112. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2012 Feb 1;30(4):419–425. Epub 2011 Dec 27. PMID: 22203767; PMCID: PMC3269967 113. Sperduto PW, Kased N, Roberge D, Chao ST, Shanley R, Luo X, Sneed PK, Suh J, Weil RJ, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M. The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol. 2013 May;112(3):467-72. Epub 2013 Mar 6. PubMed PMID: 23462853 114. Sperduto PW, Wang M, Robins HI, Schell MC, Werner-Wasik M, Komaki R, Souhami L, Buyyounouski MK, Khuntia D, Demas W, Shah SA, Nedzi LA, Perry G, Suh JH, Mehta MP. A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1312– 1318. Epub 2013 Feb 4. PMID: 23391814 115. Stewart SB, Bañez LL, Robertson CN, Freedland SJ, Polascik TJ, Xie D, Koontz BF, Vujaskovic Z, Lee WR, Armstrong AJ, Febbo PG, George DJ, Moul JW. Utilization trends at a multidisciplinary prostate cancer clinic: initial 5-year experience from the Duke Prostate Center. J Urol. 2012 Jan;187(1):103–108. Epub 2011 Nov 16. PMID: 22088334 116. Strongin A, Yovino S, Taylor R, Wolf J, Cullen K, Zimrin A, Strome S, Regine W, Suntharalingam M. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1823–1830. Epub 2011 May 5. PMID: 21549516 117. Suntharalingam M, Kwok Y, Goloubeva O, Parekh A, Taylor R, Wolf J, Zimrin A, Strome S, Ord R, Cullen KJ. Phase II study evaluating the addition of cetuximab to the concurrent delivery of weekly carboplatin, paclitaxel, and daily radiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1845–1850. Epub 2011 May 19. PMID: 21601372 118. Suntharalingam M, Paulus R, Edelman MJ, Krasna M, Burrows W, Gore E, Wilson LD, Choy H. Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):456–463. Epub 2012 Apr 28. PMID: 22543206 119. Swift JM, Lima F, Macias BR, Allen MR, Greene ES, Shirazi-Fard Y, Kupke JS, Hogan HA, Bloomfield SA. Partial weightbearing does not prevent musculoskeletal losses associated with disuse. Med Sci Sports Exerc. 2013 May 7. [Epub ahead of print] PubMed PMID: 23657172. 120. Tan S, Kligerman S, Chen W, Lu M, Kim G, Feigenberg S, D'Souza WD, Suntharalingam M, Lu W. Spatial-temporal [¹8F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1375–1382. Epub 2012 Dec 6. PMID: 23219566; PMCID: PMC3606641 121. Thomas SN, Waters KM, Morgan WF, Yang AJ, Baulch JE. Quantitative proteomic analysis of mitochondrial proteins reveals prosurvival mechanisms in the perpetuation of radiation-induced genomic instability. Free Radic Biol Med. 2012 Aug 1;53(3):618–628. Epub 2012 Apr 19. PMID: 22569412 122. Tobin LA, Robert C, Nagaria P, Chumsri S, Twaddell W, Ioffe OB, Greco GE, Brodie AH, Tomkinson AE, Rassool FV. Targeting abnormal DNA repair in therapy-resistant breast cancers. Mol Cancer Res. 2012 Jan;10(1):96–107. Epub 2011 Nov 23. PMID: 22112941; PMCID: PMC3319138 9 123. Tobin LA, Robert C, Rapoport AP, Gojo I, Baer MR, Tomkinson AE, Rassool FV. Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias. Oncogene. 2013 Apr 4;32(14):1784–1793. Epub 2012 May 28. PMID: 22641215 124. Tome WA, Gondi V, Mehta MP. In regards to Kirby et al. "Physics strategies for sparing neural stem cells during whole-brain radiation treatments," [Med. Phys. 38, 5338 (2011)]. Med Phys. 2012 Mar;39(3):1677–1678; author reply 1679. PMID: 22380400 125. Tovmasyan A, Sheng H, Weitner T, Arulpragasam A, Lu M, Warner DS, Vujaskovic Z, Spasojevic I, Batinic-Haberle I. Design, mechanism of action, bioavailability and therapeutic effects of Mn porphyrin-based redox modulators. Med Princ Pract. 2013;22(2):103–130. Epub 2012 Oct 16. PMID: 23075911; PMCID: PMC3640855. 126. Tsai HC, Li H, Van Neste L, Cai Y, Robert C, Rassool FV, Shin JJ, Harbom KM, Beaty R, Pappou E, Harris J, Yen RW, Ahuja N, Brock MV, Stearns V, Feller-Kopman D, Yarmus LB, Lin YC, Welm AL, Issa JP, Minn I, Matsui W, Jang YY, Sharkis SJ, Baylin SB, Zahnow CA. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell. 2012 Mar 20;21(3):430–446. PMID: 22439938; PMCID: PMC3312044 127. Tsao MN, Khuntia D, Mehta MP. Brain metastases: what's new with an old problem? Curr Opin Support Palliat Care. 2012 Mar;6(1):85–90. PMID: 22123260 128. Vivanco I, Robins HI, Rohle D, Campos C, Grommes C, Nghiemphu PL, Kubek S, Oldrini B, Chheda MG, Yannuzzi N, Tao H, Zhu S, Iwanami A, Kuga D, Dang J, Pedraza A, Brennan CW, Heguy A, Liau LM, Lieberman F, Yung WK, Gilbert MR, Reardon DA, Drappatz J, Wen PY, Lamborn KR, Chang SM, Prados MD, Fine HA, Horvath S, Wu N, Lassman AB, DeAngelis LM, Yong WH, Kuhn JG, Mischel PS, Mehta MP, Cloughesy TF, Mellinghoff IK. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discov. 2012 May;2(5):458–471. Epub 2012 Mar 31. PMID: 22588883; PMCID: PMC3354723 129. Voskens CJ, Sewell D, Hertzano R, DeSanto J, Rollins S, Lee M, Taylor R, Wolf J, Suntharalingam M, Gastman B, Papadimitriou JC, Lu C, Tan M, Morales R, Cullen K, Celis E, Mann D, Strome SE. Induction of MAGE-A3 and HPV-16 immunity by Trojan vaccines in patients with head and neck carcinoma. Head Neck. 2012 Dec;34(12):1734–1746. Epub 2012 Jan 27. PMID: 22287423 130. Wademan M, Ha J, Singh H, Markan Y, Sharma P, Kasamon K, Nimagada, Oh M, Citron W, Cohen R, DeLuca R, Boutros C. Current indications, techniques, and results of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for intra-abdominal malignancies. Surgery Curr Res. 2012;2(4):125. 131. Waghorn BJ, Staton RJ, Rineer JM, Meeks SL, Langen KM, A comparison of the dosimetric effects of intrafraction motion on step-and-shoot, compensator, and helical tomotherapy based IMRT. J Appl Clin Med Phys. 2013 May 6;14(3):4210. PubMed PMID: 23652252. 132. Wang L, Feigenberg S, Fan J, Jin L, Turaka A, Chen L, Ma CM. Target repositional accuracy and PTV margin verification using three-dimensional cone-beam computed tomography (CBCT) in stereotactic body radiotherapy (SBRT) of lung cancers. J Appl Clin Med Phys. 2012 Mar 8;13(2):3708. PMID: 22402387 133. Wang M, Dignam JJ, Zhang QE, DeGroot JF, Mehta MP, Hunsberger S. Integrated phase II/III clinical trials in oncology: a case study. Clin Trials. 2012 Dec;9(6):741–747. Epub 2012 Nov 22. Review. PMID: 23180870 134. Watkins AC, Wei X, Sanchez PG, Ho H, Zhang P, Hu J, Wu ZJ, Griffith BP. Evaluation of the infant Jarvik 2000 heart in a neonate piglet model. J Heart Lung Transpl. 2012;31(4):S259. 135. Weitner T, Kos I, Sheng H, Tovmasyan A, Reboucas JS, Fan P, Warner DS, Vujaskovic Z, Batinic-Haberle I, Spasojevic I. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+. Free Radic Biol Med. 2013 May;58:73–80. Epub 2013 Jan 15. PMID: 23328731 10 136. Wells KE, Weatherhead RA, Murigi FN, Nichol GS, Carducci MD, Selby HD, Mash EA. Organic crystal engineering with 1,4-piperazine-2,5-diones. 8. Synthesis, crystal packing, and thermochemistry of piperazinediones derived from 2-amino-4,7-dialkoxyindan-2-carboxylic acids. Crystal Growth Des. 2012;12:5056–5068. 137. Williams JP, Jackson IL, Shah JR, Czarniecki CW, Maidment BW, DiCarlo AL. Animal models and medical countermeasures development for radiation-induced lung damage: report from an NIAID workshop. Radiat Res. 2012;177 (5):e0025–e0039. PMID: 22468702 138. Wu J, Betzing C, He TT, Fuss M, D'Souza WD. Dosimetric comparison of patient setup strategies in stereotactic body radiation therapy for lung cancer. Med Phys. 2013 May;40(5):051709. PMID: 23635257 139. Yang X, Han-Oh S, Gui M, Niu Y, Yu CX, Yi BY. Four-dimensional dose distributions of stepand-shoot IMRT delivered with real-time tumor tracking for patients with irregular breathing: constant dose rate vs dose rate regulation. Med Phys. 2012 Sep;39(9):5557–5566. PMID: 22957622; PMCID: PMC3436918 140. Yeo IJ, Jung JW, Patyal B, Mandapaka A, Yong Yi B, Oh Kim J. Conditions for reliable timeresolved dosimetry of electronic portal imaging devices for fixed-gantry IMRT and VMAT. Med Phys. 2013 Jul;40(7):072102. PubMed PMID: 23822446. 141. Yeo IJ, Jung JW, Yi BY, Kim JO. Feasibility study on inverse four-dimensional dose reconstruction using the continuous dose-image of EPID. Med Phys. 2013 May;40(5):051702. PubMed PMID: 23635250 142. Yovino S, Maidment BW 3rd, Herman JM, Pandya N, Goloubeva O, Wolfgang C, Schulick R, Laheru D, Hanna N, Alexander R, Regine WF. Analysis of local control in patients receiving IMRT for resected pancreatic cancers. Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):916–920. Epub 2012 Jan 25. PMID: 22284684; PMCID: PMC3556989 143. Yu CX, Shao X, Zhang J, Regine W, Zheng M, Yu YS, Deng J, Duan Z. GammaPod-a new device dedicated for stereotactic radiotherapy of breast cancer. Med Phys. 2013 May;40(5):051703. PMID: 23635251; PMCID: PMC3637326 144. Yuan Y, Cheng KS, Craciunescu OI, Stauffer PR, Maccarini PF, Arunachalam K, Vujaskovic Z, Dewhirst MW, Das SK. Utility of treatment planning for thermochemotherapy treatment of nonmuscle invasive bladder carcinoma. Med Phys. 2012 Mar;39(3):1170–1181. PMID: 22380348; PMCID: PMC3292595 145. Zhang H, Diwanji T, Mistry N, Lu W, D’Souza W. TU-E-BRA-10: Personalized utility function for radiotherapy based on pulmonary ventilation of locally advanced lung cancer patients. Med Phys. 2012;39(6):3913. 146. Zhang HH, Gao S, Chen W, Shi L, D'Souza WD, Meyer RR. A surrogate-based metaheuristic global search method for beam angle selection in radiation treatment planning. Phys Med Biol. 2013 Mar 21;58(6):1933–1946. PMID: 23459411; PMCID: PMC3652383 147. Zhuang J, Zhang Z, Zhang C, Xu F. 8-OH-DPAT abolishes the pulmonary C-fiber-Mediated apneic response to fentanyl largely via acting on 5HT1A receptors in the nucleus Tractus solitarius. Am J Physiol Regul Integr Comp Physiol. 2012;303(4):R449–458. PubMed PMID: 22696579; PubMed Central PMCID: PMC3423994. 148. Zhang Z, Zhang C, Zhuang J, Xu F. Contribution of central μ-receptors to switching pulmonary Cfibers-mediated rapid shallow breathing into an apnea by fentanyl in anesthetized rats. Brain Res. 2012;1469:73–81. PMID: 22759907 149. Zhang Z, Zhang C, Zhou M, Xu F. Activation of opioid μ-receptors, but not δ- or κ-receptors, switches pulmonary C-fiber-mediated rapid shallow breathing into an apnea in anesthetized rats. Respir Physiol Neurobiol. 2012;183(3):211–217. PMID: 22796630 150. Zhang Y, Zhang X, Rabbani ZN, Jackson IL, Vujaskovic Z. Oxidative stress mediates radiation lung injury by inducing apoptosis. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):740–748. Epub 2012 Jan 21. PMID: 22270165; PMCID: PMC3649017 11 151. Zhao Y, Li T, Wei X, Bianchi G, Hu J, Sanchez PG, Xu K, Zhang P, Pittenger MF, Wu ZJ, Griffith BP. Mesenchymal stem cell transplantation improves regional cardiac remodeling following ovine infarction,. Stem Cells Transl Med. 2012;1:685–695. PubMed PMID:23197875; PubMed Central PMCID: PMC3659738. 152. Zhou S, Nissao E, Jackson IL, Leong W, Dancy L, Cuttitta F, Vujaskovic Z, Sunday ME. Radiation-induced lung injury is mitigated by blockade of gastrin-releasing peptide. Am J Pathol. 2013 Apr;182(4):1248–1254. Epub 2013 Feb 8. PMID: 23395092; PMCID: PMC3620399 12